Is it Time for Trials on Preventing Immune-Mediated Myocardial Damage?
JACC Basic Transl Sci
.
2021 Jun 28;6(6):543-545.
doi: 10.1016/j.jacbts.2021.05.005.
eCollection 2021 Jun.
Authors
Eliot G Peyster
1
,
Kenneth B Margulies
1
Affiliation
1
Cardiovascular Research Institute, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
PMID:
34222725
PMCID:
PMC8246058
DOI:
10.1016/j.jacbts.2021.05.005
No abstract available
Keywords:
autoimmune; dipeptidyl; immune checkpoint inhibitor; myocarditis; peptidase-4 inhibitor.
Publication types
Editorial
Grants and funding
R01 HL151277/HL/NHLBI NIH HHS/United States